To provide a portfolio designed to achieve high and rising income by investing globally, primarily in equities in any economic sector whilst participating in long term capital growth.
Name | % Net Assets |
---|---|
Altria | 3.0% |
Pfizer | 3.0% |
Royal Dutch Shell | 2.8% |
Bristol-Myers Squibb | 2.7% |
McDonalds | 2.6% |
Coca-Cola | 2.5% |
Merck & Co | 2.5% |
Muenchener Rueckversicherungs | 2.5% |
Unilever | 2.4% |
Koninklijke | 2.3% |
Key | % Net Assets |
---|---|
Altria | 3.0% |
Pfizer | 3.0% |
Royal Dutch Shell | 2.8% |
Bristol-Myers Squibb | 2.7% |
Other | 88.5% |
Date | 25-Jan-2023 |
---|---|
NAV | 146.60p |
Currency | GBP |
Change | -0.100p |
% | -0.07% |
YTD change | 146.60p |
YTD % | n/a |
Fund Inception | 07/02/2007 |
---|---|
Fund Manager | n/a |
TER | 0.06 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research